These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 34328587)

  • 1. Immunosuppression in Medulloblastoma: Insights into Cancer Immunity and Immunotherapy.
    Audi ZF; Saker Z; Rizk M; Harati H; Fares Y; Bahmad HF; Nabha SM
    Curr Treat Options Oncol; 2021 Jul; 22(9):83. PubMed ID: 34328587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updates on Management of Adult Medulloblastoma.
    Majd N; Penas-Prado M
    Curr Treat Options Oncol; 2019 Jun; 20(8):64. PubMed ID: 31236711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pictures worth more than a thousand words: Prediction of survival in medulloblastoma patients.
    Rabasco Meneghetti A; Zwanenburg A; Löck S
    EBioMedicine; 2020 Dec; 62():103136. PubMed ID: 33227586
    [No Abstract]   [Full Text] [Related]  

  • 4. Medulloblastoma: recent advances and directions in diagnosis and management--Part I.
    Chin HW; Maruyama Y; Young AB
    Curr Probl Cancer; 1984 May; 8(11):4-54. PubMed ID: 6383718
    [No Abstract]   [Full Text] [Related]  

  • 5. New perspectives in the treatment of adult medulloblastoma in the era of molecular oncology.
    Brandes AA; Bartolotti M; Marucci G; Ghimenton C; Agati R; Fioravanti A; Mascarin M; Volpin L; Ammannati F; Masotto B; Gardiman MP; De Biase D; Tallini G; Crisi G; Bartolini S; Franceschi E
    Crit Rev Oncol Hematol; 2015 Jun; 94(3):348-59. PubMed ID: 25600839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult medulloblastoma: prognostic factors and response to therapy at diagnosis and at relapse.
    Herrlinger U; Steinbrecher A; Rieger J; Hau P; Kortmann RD; Meyermann R; Schabet M; Bamberg M; Dichgans J; Bogdahn U; Weller M
    J Neurol; 2005 Mar; 252(3):291-9. PubMed ID: 16189725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Approaches in Targeted Therapy for Medulloblastoma in Children.
    Maier H; Dalianis T; Kostopoulou ON
    Anticancer Res; 2021 Apr; 41(4):1715-1726. PubMed ID: 33813375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coming in from the cold: overcoming the hostile immune microenvironment of medulloblastoma.
    Eisemann T; Wechsler-Reya RJ
    Genes Dev; 2022 May; 36(9-10):514-532. PubMed ID: 35680424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management and outcomes of treating pediatric medulloblastoma: an eight years' experience in an Iranian pediatric center.
    Mehrvar A; Tashvighi M; Hedayati Asl AA; Niktoreh-Mofrad N; Mehrvar N; Afsar N; Naderi A; Allebouyeh M; Qaddoumi I; Faranoush M
    Childs Nerv Syst; 2018 Apr; 34(4):639-647. PubMed ID: 29214340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medulloblastoma of the adult: results from a multicenter retrospective study by AINO (Italian Association of Neuro-Oncology) and SIN (Italian Society of Neurology).
    Gaviani P; Simonetti G; Rudà R; Franchino F; Lombardi G; Possanzini M; Squintu S; Villani V; Teriaca M; Cavallieri F; Caffo M; Salmaggi A; Bianco A; Anghileri E; Farinotti M; Tramacere I; Silvani A
    Neurol Sci; 2021 Feb; 42(2):665-671. PubMed ID: 32654010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refining Immuno-Oncology Approaches in Metastatic Prostate Cancer: Transcending Current Limitations.
    Wong RL; Yu EY
    Curr Treat Options Oncol; 2021 Jan; 22(2):13. PubMed ID: 33433743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug Repurposing in Medulloblastoma: Challenges and Recommendations.
    Hammoud H; Saker Z; Harati H; Fares Y; Bahmad HF; Nabha S
    Curr Treat Options Oncol; 2020 Nov; 22(1):6. PubMed ID: 33245404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conventional Therapies Deplete Brain-Infiltrating Adaptive Immune Cells in a Mouse Model of Group 3 Medulloblastoma Implicating Myeloid Cells as Favorable Immunotherapy Targets.
    Abbas Z; George C; Ancliffe M; Howlett M; Jones AC; Kuchibhotla M; Wechsler-Reya RJ; Gottardo NG; Endersby R
    Front Immunol; 2022; 13():837013. PubMed ID: 35309309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medulloblastoma: presentation, diagnosis and management.
    Packer RJ; Finlay JL
    Oncology (Williston Park); 1988 Sep; 2(9):35-45, 48-9. PubMed ID: 3275066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into cerebellar development and medulloblastoma.
    Bihannic L; Ayrault O
    Bull Cancer; 2016 Jan; 103(1):30-40. PubMed ID: 26688373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medulloblasoma: challenges for effective immunotherapy.
    Sonabend AM; Ogden AT; Maier LM; Anderson DE; Canoll P; Bruce JN; Anderson RC
    J Neurooncol; 2012 May; 108(1):1-10. PubMed ID: 22173741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment controversies in medulloblastoma.
    Chintagumpala M; Berg S; Blaney SM
    Curr Opin Oncol; 2001 May; 13(3):154-9. PubMed ID: 11307057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medulloblastoma: an Old Diagnosis with New Promises.
    Szalontay L; Khakoo Y
    Curr Oncol Rep; 2020 Jul; 22(9):90. PubMed ID: 32643099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medulloblastoma.
    Padovani L; André N; Gentet JC; Muracciole X
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S338. PubMed ID: 21944006
    [No Abstract]   [Full Text] [Related]  

  • 20. Childhood Medulloblastoma: An Overview.
    Suk Y; Gwynne WD; Burns I; Venugopal C; Singh SK
    Methods Mol Biol; 2022; 2423():1-12. PubMed ID: 34978683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.